Patients with diabetic retinopathy should be monitored closely
However, Novo Nordisk, Ozempics manufacturer, released results from two clinical trials in November 2025 that showed that taking an oral GLP-1 didnt slow disease progression among people with Alzheimers compared to those who took a placebo
See a full Ozempic lawsuit update timeline
Patients experiencing persistent vomiting or diarrhea should be monitored for signs of dehydration and renal dysfunction, with appropriate fluid replacement and potentially temporary discontinuation of the medication if necessary
Section 8: Conclusion Section 8: Conclusion The intersection of diabetes and mental health represents a complex clinical challenge, underscored by the intricate relationship between physical well-being and psychological health
For anyone with hypertension or cardiovascular risk, semaglutide is the safer choice by a wide margin